Table 2

Group data showing the cardiovascular effects of intravenous midazolam. Data are expressed as mean (SE)

Haemodynamic variablePrebolus (T0)On intravenous infusion
15 min (T1)1 hour (T2)
Cardiac index (l/min/m2)5.1  (0.5)3.7  (0.4) 4.6  (0.4)§
Oxygen consumption (ml/min/m2)266  (23)222  (20) 243  (24)
Mixed venous oxygen content (ml/100 ml blood)12.3  (0.9)11.6  (0.7)2-150 12.2  (0.7)
Heart rate (beats/min)125  (9)123  (8)130  (8)§
Stroke volume (ml/m2)41.8  (6.5)33.1  (4.9) 39.6  (4.7)
Systolic blood pressure (mm Hg)103  (7.3)83  (6.0) 89  (3.7)
Diastolic blood pressure (mm Hg)55  (3.5)45  (3.2)2-150 50  (2.2)
Mean arterial pressure (mm Hg)70  (4.7)58  (3.9) 62  (2.4)
Right atrial pressure (mm Hg)11  (1.1)10  (1.0)11  (0.8)
SVRI (units/m2)11.7  (1.2)13.5  (1.2)12.2  (1.8)
PVRI (units/m2)0.96  (0.3)1.63  (0.5)1.25  (0.5)
  • PVRI = pulmonary vascular resistance index; SVRI = systemic vascular resistance index.

  • 2-150 Haemodynamic change between T0 and T1: p < 0.05; haemodynamic change between T0 and T1: p ≤ 0.01; haemodynamic change between T0 and T2 : p < 0.05; § haemodynamic change between T1 and T2: p ≤ 0.01; haemodynamic change between T0 and T2: p < 0.05.